Investor Thomvest Asset Management Ltd.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Thomvest Asset Management Ltd. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-09-27 13D/A CA53272L2021 / LIMINAL BIOSCIENCES INC 2,382,359 3,249,534
2023-07-13 13D/A CA53272L2021 / LIMINAL BIOSCIENCES INC 2,382,359 2,382,359
2023-04-05 13D/A CA53272L2021 / LIMINAL BIOSCIENCES INC 23,992,231 2,382,359
2020-11-27 13D/A LMNL / Liminal Biosciences Inc 23,992,231 23,992,231
2020-11-26 13D/A LMNL / Liminal Biosciences Inc 23,202,758 23,992,231
2020-11-09 13D LMNL / Liminal Biosciences Inc 23,202,758
2019-12-13 13G REPL / Replimune Group, Inc. 16,886,970
2019-12-12 13G REPL / Replimune Group, Inc. 16,886,970